{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-017865","form_type":"8-K","ticker":"INGN","cik":"0001294133","company_name":"Inogen Inc","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.301079+00:00","generated_at":"2026-06-15T20:56:21.496493+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Inogen Q1 2023 revenue $72.2M, net loss $20.3M; sees positive adjusted EBITDA by Q4 2023","bullets":["Total revenue $72.2M, down 10.2% YoY; rental revenue up 25.4% YoY.","GAAP net loss $20.3M vs $14.2M loss in Q1 2022; adjusted net loss $14.5M vs $8.7M.","Adjusted EBITDA loss $11.8M vs $5.0M loss; expects positive adjusted EBITDA by Q4 2023.","Cash and marketable securities $174.6M; no debt outstanding.","Notified of France reimbursement for Rove 6; added two large private payers covering ~160M lives."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-017865","json":"https://secwatch.observer/filing/0000950170-23-017865.json","markdown":"https://secwatch.observer/filing/0000950170-23-017865.md","text":"https://secwatch.observer/filing/0000950170-23-017865.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023017865/0000950170-23-017865-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023017865/ingn-20230504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T20:56:21.496493+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d3c50ba35140c6727739f81d8912e9fd442538fb","claim":"Inogen Inc reported the quarter ended March 31, 2023 results: revenue $72.2 million, net income GAAP net loss of $20.3 million.","evidence_excerpt":"Inogen Announces First Quarter 2023 Financial Results Total Revenue of $72.2 Million In Line with Company Expectations Rental Revenue Year-over-Year Growth of 25% GOLETA, Calif., May 04, 2023 -- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1294133/000095017023017865/0000950170-23-017865-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$72.2 million"},{"label":"Net income","value":"GAAP net loss of $20.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}